fluorodeoxyglucose f18 has been researched along with Carcinoma, Adenosquamous in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (42.86) | 29.6817 |
| 2010's | 14 (50.00) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cui, B; Ren, F; Su, W; Wang, M; Zhao, S; Zuo, C | 1 |
| Filizoglu, N; Oksuzoglu, K; Ozguven, S | 1 |
| Bernd, K; Gasparri, ML; Genoud, S; Mueller, MD; Papadia, A | 1 |
| Chung, JH; Kim, SE; Kim, TJ; Lee, KW; Lee, Y | 1 |
| Gómez-Rio, M; Jiménez-Heffernan, A; Llamas-Elvira, JM; Ramos-Font, C; Rodríguez-Fernández, A; Sánchez Sánchez, R | 1 |
| An, YS; Jo, KS; Kim, CH; Kwon, SH; Lee, DH; Lee, SJ; Shin, YS; Yoon, JK | 1 |
| Clavero R, JM; Furnaro L, F; Ladrón de Guevara H, D; Lazo P, D; Pardo B, C; Pefaur D, R; Piottante B, A; Rodríguez D, P; Yévenes A, S | 1 |
| Jiang, L; Nie, H; Shi, H; Xiu, Y; Zhu, L | 1 |
| He, C; Hu, JB; Sun, XN; Xu, J | 1 |
| Chang, TC; Hong, JH; Hsueh, S; Lai, CH; Lee, SP; Ng, KK; Tsai, CS; Yen, TC | 1 |
| Dehdashti, F; Grigsby, PW; Huettner, PC; Kidd, EA; Rader, JS; Siegel, BA; Spencer, CR | 1 |
| Fan, W; Hu, YY; Liang, PY; Lin, XP; Sun, XR; Zhang, X | 1 |
| Chang, HP; Chang, TC; Chen, MY; Chou, HH; Hong, JH; Hsueh, S; Lai, CH; Ng, KK; Wu, TI; Yen, TC | 1 |
| Blauwgeers, H; Boersma, L; Burgers, S; Gilhuijs, K; Klomp, H; Knegjens, J; Rossi, M; Siedschlag, C; Stroom, J; van Baardwijk, A; van Loon, J; van Suylen, RJ; Vogel, W | 1 |
| Abdul-Karim, FW; Faulhaber, P; Kunos, C; Radivoyevitch, T | 1 |
| Dehdashti, F; Grigsby, PW; Schwarz, JK; Siegel, BA | 1 |
| Goya, S; Hatazawa, J; Hirata, H; Inoue, A; Kawase, I; Kida, H; Kijima, T; Kumagai, T; Kumanogoh, A; Nagatomo, I; Okumura, M; Shimosegawa, E; Tachibana, I; Takahashi, R; Takeda, Y; Yoshida, M | 1 |
| Hoh, CK; Jensen, LG; Lau, SK; Liang, Y; Mell, LK; Rose, BS; Yashar, CM | 1 |
| Choi, YJ; Huh, CY; Ki, KD; Kim, GY; Lee, JM; Lee, SK; Lim, SJ; Seol, HJ; Tong, SY | 1 |
| Asaka, M; Kato, T; Katoh, C; Kondo, S; Kuge, Y; Nambu, T; Nobuta, A; Tamaki, N; Tsukamoto, E | 1 |
| Dehdashti, F; Grigsby, PW; Miller, TR; Pinkus, E | 1 |
| Dehdashti, F; Grigsby, PW; Mutch, DG; Siegel, BA | 1 |
| Dehdashti, F; Grigsby, PW; Herzog, TJ; Siegel, BA; Singh, AK | 1 |
| Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 1 |
| Grigsby, PW; Hope, AJ; Saha, P | 1 |
| Grigsby, PW; Lin, LL; Miller, TR; Mutic, S; Yang, Z | 1 |
| Ikeda, K; Katahira, K; Kawanaka, K; Mori, T; Nomori, H; Shiraishi, S; Yamashita, Y | 1 |
| Grigsby, PW; Miller, TR | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
Topics: Adult; Aged; Aorta; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2010 |
Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
26 other study(ies) available for fluorodeoxyglucose f18 and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
Topics: Carcinoma, Adenosquamous; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Primary Adenosquamous Carcinoma of the Liver on FDG PET/CT.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Adenosquamous; Female; Fluorodeoxyglucose F18; Humans; Liver; Positron Emission Tomography Computed Tomography | 2021 |
The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Carcinoma, Adenosquamous; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Uterine Cervical Neoplasms | 2017 |
Adenosquamous carcinoma of the lung: CT, FDG PET, and clinicopathologic findings.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Ability of FDG-PET/CT in the detection of gallbladder cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Carcinoma, Adenosquamous; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Prognostic significance of the intratumoral heterogeneity of (18) F-FDG uptake in oral cavity cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed | 2014 |
[Positron emission tomography/computed tomography for lung cancer staging].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Adenosquamous Carcinoma of the Pancreas Demonstrated on 18F-FDG PET/CT Imaging.
Topics: Aged; Carcinoma, Adenosquamous; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Port site and distant metastases of gallbladder cancer after laparoscopic cholecystectomy diagnosed by positron emission tomography.
Topics: Aged; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cholecystectomy, Laparoscopic; Cholecystitis; Cholelithiasis; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Incidental Findings; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Seeding; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2009 |
[Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Serpins; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
(18)F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Area Under Curve; Carcinoma, Adenosquamous; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Prognosis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tumor Burden; Uterine Cervical Neoplasms | 2010 |
Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Biological; Neoplasm Invasiveness; Netherlands; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Regression Analysis; Risk Factors; Tomography, X-Ray Computed; Tumor Burden | 2012 |
18F-fluoro-2-deoxy-D-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2011 |
Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cervix Uteri; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Failure; Uterine Cervical Neoplasms; Uterus; Young Adult | 2012 |
Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lung.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Adenosquamous; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Mutation; Positron-Emission Tomography; Prognosis; Quinazolines; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2012 |
Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Bone Marrow; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Hematologic Diseases; Humans; Leukocyte Count; Linear Models; Middle Aged; Neutrophils; Platelet Count; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2012 |
Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Hexokinase; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Observer Variation; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multivariate Analysis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Adenosquamous; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carcinosarcoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
FDG-PET in carcinoma of the uterine cervix with endometrial extension.
Topics: Adenocarcinoma; Carcinoma, Adenosquamous; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cervix Uteri; Combined Modality Therapy; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Uterine Cervical Neoplasms | 2006 |
FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2006 |
Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Diagnostic Imaging; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2002 |